Review
One year in review: novelties in the treatment of rheumatoid arthritis
G.M. Guidelli1, T. Barskova2, M.G. Brizi3, G. Lepri4, A. Parma5, R. Talarico6, L. Cantarini7, B. Frediani8
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
- Rheumatology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
- Rheumatology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
CER8389
2015 Vol.33, N°1
PI 0102, PF 0108
Review
Free to view
(click on article PDF icon to read the article)
PMID: 25719499 [PubMed]
Received: 20/02/2015
Accepted : 23/02/2015
In Press: 26/02/2015
Published: 04/03/2015
Abstract
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary aim of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. In this article, we provide a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last two years.
